TNFSF13B and systemic lupus erythematosus: There is a clear-cut association in BlyS transgenic mice between BLyS overexpression and development of SLE-like features [3-5], and treatment of SLE-prone mice with BLyS antagonists retards the progression of disease and improves survival [3,6].